Mycosis Fungoides: Pathophysiology and Emerging Therapies
Duvic M, Foss FM. Mycosis Fungoides: Pathophysiology and Emerging Therapies. Seminars In Oncology 2007, 34: s21-s28. PMID: 18086343, DOI: 10.1053/j.seminoncol.2007.11.006.Peer-Reviewed Original ResearchMeSH KeywordsClinical Trials as TopicHistone DeacetylasesHumansImmunologic FactorsMycosis FungoidesPurine NucleosidesPurine-Nucleoside PhosphorylasePyrimidinonesSezary SyndromeSkin NeoplasmsConceptsCutaneous T-cell lymphomaMycosis fungoidesRefractory cutaneous T-cell lymphomaPrimary cutaneous T-cell lymphomaNeoplastic T lymphocytesSafe treatment strategyNon-Hodgkin lymphomaT-cell lymphomaLeukemic variant Sézary syndromeHistone deacetylase inhibitorsOrgan complicationsSystemic regimensCutaneous manifestationsEmerging TherapiesSézary syndromeSkin infiltrationSystemic therapyBiologic agentsCTCL subtypesTreatment strategiesCurrent treatmentT lymphocytesDeacetylase inhibitorsPurine nucleoside phosphorylase inhibitorTherapy
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply